ATE374525T1 - Transgenes fibrinogen - Google Patents

Transgenes fibrinogen

Info

Publication number
ATE374525T1
ATE374525T1 AT95911012T AT95911012T ATE374525T1 AT E374525 T1 ATE374525 T1 AT E374525T1 AT 95911012 T AT95911012 T AT 95911012T AT 95911012 T AT95911012 T AT 95911012T AT E374525 T1 ATE374525 T1 AT E374525T1
Authority
AT
Austria
Prior art keywords
fibrinogens
animals
modified
human
subunit
Prior art date
Application number
AT95911012T
Other languages
English (en)
Inventor
William Velander
Susan Lord
William Drohan
Henryk Lubon
John Johnson
Christopher Russell
Original Assignee
American Nat Red Cross
Virginia Tech Intell Prop
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Nat Red Cross, Virginia Tech Intell Prop, Univ North Carolina filed Critical American Nat Red Cross
Application granted granted Critical
Publication of ATE374525T1 publication Critical patent/ATE374525T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95911012T 1994-02-18 1995-02-17 Transgenes fibrinogen ATE374525T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19806894A 1994-02-18 1994-02-18

Publications (1)

Publication Number Publication Date
ATE374525T1 true ATE374525T1 (de) 2007-10-15

Family

ID=22731871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95911012T ATE374525T1 (de) 1994-02-18 1995-02-17 Transgenes fibrinogen

Country Status (9)

Country Link
EP (1) EP0744891B1 (de)
JP (1) JPH10500003A (de)
AT (1) ATE374525T1 (de)
CA (1) CA2183546C (de)
DE (1) DE69535604T2 (de)
DK (1) DK0744891T3 (de)
ES (1) ES2296289T3 (de)
PT (1) PT744891E (de)
WO (1) WO1995022249A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024887A2 (en) * 2000-09-19 2002-03-28 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
DE69841459D1 (en) * 1997-02-14 2010-03-11 American Nat Red Cross Expression des active human factor ix im brustdrüsengewebe transgener tiere
US20020184655A1 (en) * 1997-12-01 2002-12-05 Henryk Lubon Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
WO2000015772A2 (en) * 1998-09-16 2000-03-23 Nexia Biotechnologies, Inc. Recombinant protein production in urine
DK1115745T3 (da) * 1998-09-24 2006-10-02 Pharming Intellectual Pty Bv Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
AU765315B2 (en) * 1998-11-19 2003-09-18 Pharming Intellectual Property Bv Stabilisation of milk from transgenic animals
US7030289B2 (en) 1998-11-19 2006-04-18 Ppl Therapeutics (Scotland) Ltd Stabilization of milk from transgenic animals
GB9825374D0 (en) * 1998-11-19 1999-01-13 Ppl Therapeutics Scotland Ltd Method
CN1747970A (zh) 2003-02-06 2006-03-15 三肽公司 抗原/抗体或配体/受体糖基化的特异性交换剂
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
WO2005010178A1 (ja) * 2003-07-29 2005-02-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 組換えフィブリノゲン高産生細胞の作製方法及び高産生細胞
US8557773B2 (en) 2008-05-02 2013-10-15 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Treatment of bleeding with low half-life fibrinogen
WO2010129258A2 (en) 2009-04-27 2010-11-11 Mallinckrodt Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
EP2547337A1 (de) 2010-03-17 2013-01-23 Pharming Intellectual Property B.V. Verwendung von antikoagulanzien bei der herstellung von rekombinanten proteinen in der milch von transgenen tieren
JP5839810B2 (ja) 2011-03-03 2016-01-06 日本製粉株式会社 フィブリノゲンを産生するトランスジェニックカイコ
EP2556842A1 (de) 2011-08-11 2013-02-13 Bioftalmik, S.L. Zusammensetzung in Form einer Folie mit Fibrinogen und Fibrinogenaktivator sowie Anwendungen dafür

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1228592A (en) * 1991-01-11 1992-08-17 American Red Cross Expression of active human protein c in mammary tissue of transgenic animals

Also Published As

Publication number Publication date
EP0744891B1 (de) 2007-10-03
WO1995022249A1 (en) 1995-08-24
CA2183546A1 (en) 1995-08-24
CA2183546C (en) 2001-08-21
PT744891E (pt) 2008-01-14
DK0744891T3 (da) 2008-02-04
ES2296289T3 (es) 2008-04-16
DE69535604D1 (en) 2007-11-15
EP0744891A1 (de) 1996-12-04
DE69535604T2 (de) 2008-05-21
JPH10500003A (ja) 1998-01-06

Similar Documents

Publication Publication Date Title
DK0744891T3 (da) Transgene fibrinogener
EP0737746A3 (de) Herstellung rekombinanter Polypeptide durch Rinderarte und Transgenmethoden
AU573523B2 (en) Functional human urokinase proteins
ATE298801T1 (de) Fibrinogenproduktion in transgenen tieren
ATE391181T1 (de) Bioaktive il-12 fusionsproteine
DK1218504T3 (da) GL50 molekyler og anvendelser deraf
DE3752130D1 (de) Herstellung von peptiden
WO1996034966A3 (en) Engineering protein posttranslational modification in transgenic organisms
ATE273388T1 (de) Veränderte menschliche c3-proteine
DK175989A (da) Fremgangsmaade til fremstilling af protein
WO2001019846A8 (en) Transgenically produced fusion proteins
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
ATE294861T1 (de) Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen
EP1147184A4 (de) Kontrollierte expression von heterologen proteinen in der milchdrüse eines transgenen tieres
WO2001090146A3 (en) 57256 and 58289, human transporters and uses thereof
ATE36348T1 (de) Herstellungsverfahren und selektive isolierung von proteinen und polypeptiden, rekombinant und expressionsvektor dazu und schmelzprotein das zum konstanten teil von immoglobulinen binden kann.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0744891

Country of ref document: EP